In vivo CRISPR screening reveals epigenetic regulators of hepatobiliary plasticity

Authors:

Abstract
Following prolonged liver injury, a small fraction of hepatocytes undergoes reprogramming to become cholangiocytes or biliary epithelial cells (BECs). This physiological process involves chromatin and transcriptional remodeling, but the epigenetic mediators are largely unknown. Here, we exploited a lineage-traced model of liver injury to investigate the role of histone post-translational modification in biliary reprogramming. Using mass spectrometry, we defined the repertoire of histone marks that are globally altered in quantity during reprogramming. Next, applying an in vivo CRISPR screening approach, we identified seven histone-modifying enzymes that alter the efficiency of hepatobiliary reprogramming. Among these, the histone methyltransferase and demethylaseNsd1andKdm2awere found to have reciprocal effects on H3K36 methylation that regulated the early and late stages of reprogramming, respectively. Although loss ofNsd1andKdm2aaffected reprogramming efficiency, cells ultimately acquired the same transcriptomic states. These findings reveal that multiple chromatin regulators exert dynamic and complementary activities to achieve robust cell fate switching, serving as a model for the cell identity changes that occur in various forms of physiological metaplasia or reprogramming.
Funding Information
  • National Institutes of Health (R01DK083355, R01DK125387, HD106051, CA196539)
  • Fred and Suzanne Biesecker Pediatric Liver Center
  • Abramson Family Cancer Research Institute
  • International Medical Research Foundation
  • Daiichi Sankyo Foundation of Life Science
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Mitsukoshi Health and Welfare Foundation
  • Uehara Memorial Foundation
  • Kanae Foundation
  • Japanese Biochemical Society
  • Osamu Hayaishi Memorial Scholarship